Roundview Capital’s Pfizer PFE Stock Holding History

Roundview Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$631K	Sell	22,484 -4,129	-16%	-$110K	0.04%	244
2025 Q4	$663K	Buy	26,613 +1,950	+8%	+$49.2K	0.04%	229
2025 Q3	$628K	Sell	24,663 -225	-0.9%	-$5.55K	0.04%	245
2025 Q2	$603K	Sell	24,888 -4,381	-15%	-$102K	0.04%	251
2025 Q1	$742K	Sell	29,269 -10,425	-26%	-$273K	0.05%	227
2024 Q4	$1.05M	Sell	39,694 -1,218	-3%	-$33K	0.07%	209
2024 Q3	$1.18M	Sell	40,912 -1,829	-4%	-$53.4K	0.09%	204
2024 Q2	$1.2M	Sell	42,741 -4,117	-9%	-$113K	0.09%	186
2024 Q1	$1.3M	Sell	46,858 -3,762	-7%	-$104K	0.11%	181
2023 Q4	$1.46M	Sell	50,620 -10,577	-17%	-$320K	0.13%	153
2023 Q3	$2.03M	Sell	61,197 -2,314	-4%	-$81.8K	0.2%	110
2023 Q2	$2.33M	Buy	63,511 +500	+0.8%	+$19.5K	0.23%	103
2023 Q1	$2.57M	Sell	63,011 -3,363	-5%	-$145K	0.27%	93
2022 Q4	$3.4M	Buy	66,374 +2,416	+4%	+$116K	0.39%	74
2022 Q3	$2.8M	Sell	63,958 -184	-0.3%	-$8.94K	0.35%	75
2022 Q2	$3.36M	Sell	64,142 -588	-0.9%	-$30K	0.4%	68
2022 Q1	$3.35M	Buy	64,730 +970	+2%	+$50.3K	0.34%	82
2021 Q4	$3.77M	Sell	63,760 -2,919	-4%	-$145K	0.38%	70
2021 Q3	$2.87M	Buy	66,679 +12,627	+23%	+$559K	0.32%	85
2021 Q2	$2.12M	Sell	54,052 -8,251	-13%	-$321K	0.24%	111
2021 Q1	$2.26M	Sell	62,303 -2,687	-4%	-$95.4K	0.28%	90
2020 Q4	$2.39M	Sell	64,990 -5,472	-8%	-$201K	0.33%	80
2020 Q3	$2.45M	Sell	70,462 -155	-0.2%	-$5.43K	0.38%	66
2020 Q2	$2.19M	Sell	70,617 -5,635	-7%	-$191K	0.37%	68
2020 Q1	$2.36M	Sell	76,252 -9,014	-11%	-$307K	0.5%	51
2019 Q4	$3.17M	Sell	85,266 -3,803	-4%	-$135K	0.6%	42
2019 Q3	$3.04M	Buy	89,069 +6,148	+7%	+$224K	0.66%	39
2019 Q2	$3.41M	Sell	82,921 -1,591	-2%	-$63.2K	0.77%	30
2019 Q1	$3.4M	Buy	84,512 +7,159	+9%	+$287K	0.81%	32
2018 Q4	$3.2M	Buy	77,353 +5,951	+8%	+$247K	0.9%	28
2018 Q3	$2.98M	Buy	71,402 +12,887	+22%	+$496K	0.74%	33
2018 Q2	$2.01M	Buy	58,515 +57	+0.1%	+$1.95K	0.53%	56
2018 Q1	$1.97M	Sell	58,458 -6,582	-10%	-$226K	0.55%	53
2017 Q4	$2.23M	Buy	65,040 +222	+0.3%	+$7.57K	0.58%	53
2017 Q3	$2.19M	Sell	64,818 -4,449	-6%	-$143K	0.63%	48
2017 Q2	$2.21M	Buy	69,267 +11,113	+19%	+$350K	0.64%	47
2017 Q1	$1.89M	Buy	58,154 +26	+0%	+$820	0.59%	60
2016 Q4	$1.79M	Buy	58,128 +5,059	+10%	+$154K	0.57%	58
2016 Q3	$1.71M	Buy	53,069 +1,012	+2%	+$33.8K	0.6%	52
2016 Q2	$1.74M	Sell	52,057 -1,318	-2%	-$42.1K	0.64%	50
2016 Q1	$1.5M	Sell	53,375 -5,091	-9%	-$145K	0.56%	57
2015 Q4	$1.79M	Buy	58,466 +3,329	+6%	+$105K	0.71%	43
2015 Q3	$1.64M	Buy	55,137 +14,603	+36%	+$468K	0.7%	39
2015 Q2	$1.29M	Sell	40,534 -524	-1%	-$17.1K	0.49%	65
2015 Q1	$1.35M	Buy	41,058 +1,160	+3%	+$36.9K	0.54%	61
2014 Q4	$1.18M	Sell	39,898 -1,642	-4%	-$47.1K	0.48%	70
2014 Q3	$1.17M	Sell	41,540 -1,270	-3%	-$35.6K	0.52%	63
2014 Q2	$1.21M	Buy	42,810 +2,914	+7%	+$83.1K	0.49%	75
2014 Q1	$1.22M	Sell	39,896 -2,035	-5%	-$60.7K	0.59%	62
2013 Q4	$1.22M	Sell	41,931 -373	-0.9%	-$10.9K	0.56%	63
2013 Q3	$1.15M	Buy	42,304 +337	+0.8%	+$9.17K	0.6%	58
2013 Q2	$1.11M	Buy	+41,967	New	+$1.16M	0.7%	47

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Roundview Capital's PFE Position: Q1 2026 in Review

Roundview Capital reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $110K and leaving 22,484 shares worth $631K. The position accounts for 0.04% of the portfolio, ranked #244.

Roundview Capital first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.77M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Roundview Capital held 22,484 shares of Pfizer worth $631K as of Q1 2026.
Roundview Capital sold 4,129 Pfizer shares in Q1 2026, an estimated $110K.
Pfizer made up 0.04% of Roundview Capital's portfolio in Q1 2026, its #244 holding.
Roundview Capital first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Roundview Capital's Pfizer position peaked at $3.77M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.